Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials.
CONCLUSIONS: Vortioxetine is not associated with increased risk of suicidal ideation or behavior in MDD patients.
PMID: 31199210 [PubMed - as supplied by publisher]
Source: CNS Spectrums - Category: Neurology Authors: Mahableshwarkar AR, Affinito J, Reines EH, Xu J, Nomikos G, Jacobsen PL Tags: CNS Spectr Source Type: research